Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Array Biopharma Inc (NASDAQ:ARRY)

10.87
Delayed Data
As of Jan 13
 +0.76 / +7.52%
Today’s Change
2.38
Today|||52-Week Range
11.22
+23.66%
Year-to-Date
After ARIAD's Acquisition, These 3 Cancer Drug Stocks Could Be Next
Jan 10 / MotleyFool.com - Paid Partner Content
Why Array BioPharma Inc Stock Surged 108.3% in 2016
Jan 09 / MotleyFool.com - Paid Partner Content

Today’s Trading

Previous close10.11
Today’s open10.17
Day’s range10.17 - 11.22
Volume11,135,358
Average volume (3 months)5,916,965
Market cap$1.8B
Dividend yield--
Data as of 4:00pm ET, 01/13/2017

Growth & Valuation

Earnings growth (last year)-1,028.57%
Earnings growth (this year)-18.63%
Earnings growth (next 5 years)+16.00%
Revenue growth (last year)+165.62%
P/E ratioNM
Price/Sales3.69
Price/Book--

Competitors

 Today’s
change
Today’s
% change
CBMCambrex Corp+0.65+1.18%
AGIOAgios Pharmaceutical...-0.06-0.14%
PRTAProthena Corporation...-0.01-0.02%
TBPHTheravance Biopharma...-0.06-0.18%
Data as of 4:02pm ET, 01/13/2017

Financials

Next reporting dateFebruary 7, 2017
EPS forecast (this quarter)-$0.18
Annual revenue (last year)$137.9M
Annual profit (last year)-$92.8M
Net profit margin-67.33%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Ron Squarer
Chief Operating Officer
Andrew R. Robbins
Corporate headquarters
Boulder, Colorado

Forecasts


Search for Jobs